Yolanda Taylor

Yolanda Taylor is a seasoned professional in medical writing and regulatory affairs, currently serving as the Head of Medical Writing at Boehringer Ingelheim since July 2019, where leadership encompasses global clinical regulatory medical writing across various therapeutic areas and regions. Prior experience includes a role as Sr Director of Regulatory Affairs Medical Writing at Medpace, and extensive tenure at Eli Lilly and Company, where positions ranged from Director of Scientific Communications to Director of Global Medical Quality. Yolanda's background also includes a Six Sigma Black Belt designation, indicating expertise in process improvement across medical, marketing, and clinical operations. Yolanda holds a Doctor of Pharmacy (Pharm.D.) and a bachelor's degree in Biology from The University of Kansas.